Chronic Granulomatous Disease clinical trials at UCSF

1 research study open to eligible people

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
open to all eligible people
This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.
San Francisco, California and other locations

Last updated: February 7, 2025